{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-062492","form_type":"8-K","ticker":"INGN","cik":"0001294133","company_name":"Inogen Inc","filed_at":"2023-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.551646+00:00","generated_at":"2026-06-08T04:41:04.908849+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Inogen names Kevin Smith President and CEO; new compensation includes $1.7M sign-on bonus","bullets":["Kevin Smith appointed President and CEO effective Nov 10, 2023, succeeding Nabil Shabshab who departed same day.","Smith brings over 20 years med-device leadership, most recently CEO of Sirtex Medical.","Compensation: $700K salary, 100% target bonus, $1.7M sign-on bonus (two installments), 170K equity (RSUs + PSUs).","Full-year 2023 financial guidance reaffirmed; company will skip Stifel and Piper Sandler conferences."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-062492","json":"https://secwatch.observer/filing/0000950170-23-062492.json","markdown":"https://secwatch.observer/filing/0000950170-23-062492.md","text":"https://secwatch.observer/filing/0000950170-23-062492.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1294133/000095017023062492/0000950170-23-062492-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1294133/000095017023062492/ingn-20231110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T04:41:04.908849+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3d88376214","claim":"Kevin Smith was appointed as Class III director at Inogen Inc.","evidence_excerpt":"appointed Mr. Smith to serve as a Class III director of the Company, effective November 10, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1294133/000095017023062492/0000950170-23-062492-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III director"}],"fact_type":"executive_change"},{"claim_id":"6115f54d6a","claim":"Kevin Smith was appointed as President and Chief Executive Officer at Inogen Inc.","evidence_excerpt":"appointed Kevin Smith to serve as President and Chief Executive Officer (\"CEO\") of the Company, effective November 10, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1294133/000095017023062492/0000950170-23-062492-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"6f994b8a00","claim":"Nabil Shabshab departed as President and Chief Executive Officer at Inogen Inc.","evidence_excerpt":"Mr. Shabshab's role as an officer and employee of the Company ended effective November 10, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1294133/000095017023062492/0000950170-23-062492-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ended"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}